Personal Injury Attorneys Win the Right To Settle DES-Breast Cancer Cases in Mediation

  • Home
  • »
  • Blog
  • »
  • Personal Injury Attorneys Win the Right To Settle DES-Breast Cancer Cases in Mediation

Personal injury attorneys are thrilled that a class-action suit in Boston will go to mediation after a federal judge ruled that the claims of 53 breast cancer patients should not be dismissed. The suit alleges that the women were exposed to diethylstilbestrol (DES) while in their mothers’ womb, which led to their diagnoses of developing breast cancer.

philadelphia medical malpractice lawyers | new jersey medical malpractice lawyersDES is a synthetic estrogen that was prescribed to pregnant women to prevent miscarriages up until 1971 when the Food and Drug Administration (FDA) issued a bulletin advising physicians not to give DES to pregnant women. DES has continued to be researched and has since been linked to a number of health risks associated with exposure to the drug. Women exposed to DES before birth (in the womb), known as DES Daughters, are at an increased risk for clear cell adenocarcinoma (CCA) of the vagina and cervix, reproductive tract structural differences, pregnancy complications, and infertility.

Like DES Daughters, DES Sons are men who were exposed to DES before birth (in the womb). They are at an increased risk for non-cancerous epididymal cysts.

Personal Injury Attorneys Contend that Drug Companies Knew About the Dangers Associated with DES

The lawsuit names 14 drug companies, including Bristol-Myers Squibb Co. and Eli Lilly & Co., who manufactured and marketed DES to pregnant women from 1938 until 1971. Personal injury attorneys for the plaintiffs argue that the companies withheld reports that showed DES did not prevent miscarriages from doctors and the FDA. They also say the reports raised serious questions about the drug’s safety.

Although no firm link between DES and breast cancer have been established, US District Judge Marianne Bowler wrote in her decision that there’s been an “observed association” between breast cancer and in utero exposure to DES in a number of “relevant published studies” that suggest a causal link.

New Jersey and Philadelphia Personal Injury Attorneys

The Philadelphia personal injury attorneys at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries. Our extremely skilled team of personal injury attorneys and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you have been injured by a defective drug, a negligent medical provider, or have endured any other type of personal injury, contact the personal injury attorneys of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw, submit a free online inquiry.


Call the Philadelphia personal injury lawyers of Messa & Associates today to discuss your case with a professional who has the knowledge to answer your questions or submit a free online inquiry.

Call, toll-free, 1-877-MessaLaw (637-7252), or submit a free online inquiry form.

About the Author:

Director of Marketing for Messa & Associates located in Philadelphia, Pennsylvania. For all marketing or press release communications, contact

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}